GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Keratin, type II cytoskeletal 75 (Cytokeratin-75) (CK-75) (Keratin-6 hair follicle) (hK6hf) (Keratin-75) (K75) (Type II keratin-K6hf) (Type-II keratin Kb18)

 K2C75_HUMAN             Reviewed;         551 AA.
O95678; B4DQU4; Q9NSA9;
15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
16-JUN-2009, sequence version 2.
13-FEB-2019, entry version 136.
RecName: Full=Keratin, type II cytoskeletal 75;
AltName: Full=Cytokeratin-75;
Short=CK-75;
AltName: Full=Keratin-6 hair follicle;
Short=hK6hf;
AltName: Full=Keratin-75;
Short=K75;
AltName: Full=Type II keratin-K6hf;
AltName: Full=Type-II keratin Kb18;
Name=KRT75; Synonyms=K6HF, KB18;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANTS GLY-91
AND ARG-485.
TISSUE=Hair follicle;
PubMed=9856802; DOI=10.1046/j.1523-1747.1998.00456.x;
Winter H., Langbein L., Praetzel S., Jacobs M., Rogers M.A.,
Leigh I.M., Tidman N., Schweizer J.;
"A novel human type II cytokeratin, K6hf, specifically expressed in
the companion layer of the hair follicle.";
J. Invest. Dermatol. 111:955-962(1998).
[2]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS GLY-91 AND ARG-485.
PubMed=10692104; DOI=10.1046/j.1523-1747.2000.00910.x;
Rogers M.A., Winter H., Langbein L., Wolf C., Schweizer J.;
"Characterization of a 300 kbp region of human DNA containing the type
II hair keratin.";
J. Invest. Dermatol. 114:464-472(2000).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=16541075; DOI=10.1038/nature04569;
Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
Kucherlapati R., Weinstock G., Gibbs R.A.;
"The finished DNA sequence of human chromosome 12.";
Nature 440:346-351(2006).
[5]
TISSUE SPECIFICITY.
PubMed=14675170; DOI=10.1111/j.1523-1747.2003.12644.x;
Wang Z., Wong P., Langbein L., Schweizer J., Coulombe P.A.;
"Type II epithelial keratin 6hf (K6hf) is expressed in the companion
layer, matrix, and medulla in anagen-stage hair follicles.";
J. Invest. Dermatol. 121:1276-1282(2003).
[6]
TISSUE SPECIFICITY.
PubMed=15292489; DOI=10.1152/physiolgenomics.00134.2004;
Roh C., Tao Q., Lyle S.;
"Dermal papilla-induced hair differentiation of adult epithelial stem
cells from human skin.";
Physiol. Genomics 19:207-217(2004).
[7]
TISSUE SPECIFICITY.
PubMed=18032949; DOI=10.1097/DAD.0b013e318158d741;
Perrin C.;
"Expression of follicular sheath keratins in the normal nail with
special reference to the morphological analysis of the distal nail
unit.";
Am. J. Dermatopathol. 29:543-550(2007).
[8]
VARIANT LAHS LYS-337.
PubMed=11939812; DOI=10.1001/archderm.138.4.501;
Chapalain V., Winter H., Langbein L., Le Roy J.-M., Labreze C.,
Nikolic M., Schweizer J., Taieb A.;
"Is the loose anagen hair syndrome a keratin disorder? A clinical and
molecular study.";
Arch. Dermatol. 138:501-506(2002).
[9]
VARIANT THR-161, CHARACTERIZATION OF VARIANT THR-161, AND ASSOCIATION
WITH INCREASED RISK TO DEVELOP PFB.
PubMed=15086549; DOI=10.1111/j.0022-202X.2004.22309.x;
Winter H., Schissel D., Parry D.A.D., Smith T.A., Liovic M.,
Birgitte Lane E., Edler L., Langbein L., Jave-Suarez L.F.,
Rogers M.A., Wilde J., Peters G., Schweizer J.;
"An unusual Ala12Thr polymorphism in the 1A alpha-helical segment of
the companion layer-specific keratin K6hf: evidence for a risk factor
in the etiology of the common hair disorder pseudofolliculitis
barbae.";
J. Invest. Dermatol. 122:652-657(2004).
-!- FUNCTION: Plays a central role in hair and nail formation.
Essential component of keratin intermediate filaments in the
companion layer of the hair follicle.
-!- SUBUNIT: Heterodimer of a type I and a type II keratin. May
associate with KRT17. {ECO:0000250}.
-!- INTERACTION:
O76011:KRT34; NbExp=4; IntAct=EBI-2949715, EBI-1047093;
Q8NI38:NFKBID; NbExp=4; IntAct=EBI-2949715, EBI-10271199;
Q1A5X7:WHAMMP3; NbExp=4; IntAct=EBI-2949715, EBI-11956783;
-!- TISSUE SPECIFICITY: Highly expressed in hair follicles from scalp.
Specifically expressed in the of the hair companion layer
follicle, a single layered band of flat and vertically oriented
cells between the cuboidal outer root sheath (ORS) cells and the
inner root sheath (IRS) that stretches from the lowermost bulb
region to the isthmus of the follicle. Also expressed in
medullated hairs. In nails, it is almost exclusively present in
the nail bed (at protein level). {ECO:0000269|PubMed:14675170,
ECO:0000269|PubMed:15292489, ECO:0000269|PubMed:18032949,
ECO:0000269|PubMed:9856802}.
-!- POLYMORPHISM: The Thr-161 variant may increase risk to develop
pseudofolliculitis barbae (PFB) [MIM:612318]. PFB is a common hair
disorder characterized by a pustular foreign body inflammatory
reaction that is induced by ingrown hairs of the facial and
submental (barbea) regions after regular shaving. It occurs
predominantly in black males, while it is rather rare and usually
far less severe in Caucasian males.
-!- DISEASE: Loose anagen hair syndrome (LAHS) [MIM:600628]: In LAHS,
anagen hairs are easily pulled from the scalp. The hair is
relatively sparse and does not grow long. Hair of fair color and
hair shafts of reduced caliber, and an early age of onset are
features. Usually the hairs are not fragile and there are no areas
of breakage. {ECO:0000269|PubMed:11939812}. Note=The disease may
be caused by mutations affecting the gene represented in this
entry.
-!- MISCELLANEOUS: May be used as a marker of hair differentiation.
-!- MISCELLANEOUS: There are two types of cytoskeletal and
microfibrillar keratin, I (acidic) and II (neutral to basic) (40-
55 and 56-70 kDa, respectively).
-!- SIMILARITY: Belongs to the intermediate filament family.
{ECO:0000255|PROSITE-ProRule:PRU01188}.
-!- SEQUENCE CAUTION:
Sequence=BAG61056.1; Type=Erroneous initiation; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; Y17282; CAA76730.1; -; mRNA.
EMBL; Y19212; CAB76832.1; -; Genomic_DNA.
EMBL; AK298960; BAG61056.1; ALT_INIT; mRNA.
EMBL; AC055736; -; NOT_ANNOTATED_CDS; mRNA.
CCDS; CCDS8827.1; -.
RefSeq; NP_004684.2; NM_004693.2.
UniGene; Hs.697046; -.
ProteinModelPortal; O95678; -.
SMR; O95678; -.
BioGrid; 114567; 20.
IntAct; O95678; 131.
STRING; 9606.ENSP00000252245; -.
Allergome; 415; Hom s 5.
iPTMnet; O95678; -.
PhosphoSitePlus; O95678; -.
SwissPalm; O95678; -.
BioMuta; KRT75; -.
EPD; O95678; -.
jPOST; O95678; -.
PaxDb; O95678; -.
PeptideAtlas; O95678; -.
PRIDE; O95678; -.
ProteomicsDB; 50995; -.
DNASU; 9119; -.
Ensembl; ENST00000252245; ENSP00000252245; ENSG00000170454.
GeneID; 9119; -.
KEGG; hsa:9119; -.
UCSC; uc001saj.3; human.
CTD; 9119; -.
DisGeNET; 9119; -.
EuPathDB; HostDB:ENSG00000170454.5; -.
GeneCards; KRT75; -.
H-InvDB; HIX0036863; -.
HGNC; HGNC:24431; KRT75.
HPA; HPA019367; -.
HPA; HPA076201; -.
MalaCards; KRT75; -.
MIM; 600628; phenotype.
MIM; 609025; gene.
MIM; 612318; phenotype.
neXtProt; NX_O95678; -.
OpenTargets; ENSG00000170454; -.
PharmGKB; PA147357763; -.
eggNOG; ENOG410IG4R; Eukaryota.
eggNOG; ENOG410YY6B; LUCA.
GeneTree; ENSGT00940000155862; -.
HOGENOM; HOG000230976; -.
HOVERGEN; HBG013015; -.
InParanoid; O95678; -.
KO; K07605; -.
OMA; YNLGGAK; -.
OrthoDB; 824246at2759; -.
PhylomeDB; O95678; -.
TreeFam; TF317854; -.
Reactome; R-HSA-6805567; Keratinization.
Reactome; R-HSA-6809371; Formation of the cornified envelope.
GenomeRNAi; 9119; -.
PRO; PR:O95678; -.
Proteomes; UP000005640; Chromosome 12.
Bgee; ENSG00000170454; Expressed in 35 organ(s), highest expression level in hair follicle.
Genevisible; O95678; HS.
GO; GO:0005829; C:cytosol; TAS:Reactome.
GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
GO; GO:0005882; C:intermediate filament; IDA:CACAO.
GO; GO:0045095; C:keratin filament; IEA:InterPro.
GO; GO:0005198; F:structural molecule activity; TAS:ProtInc.
GO; GO:0070268; P:cornification; TAS:Reactome.
GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl.
GO; GO:0031424; P:keratinization; TAS:Reactome.
InterPro; IPR001664; IF.
InterPro; IPR018039; IF_conserved.
InterPro; IPR039008; IF_rod_dom.
InterPro; IPR032444; Keratin_2_head.
InterPro; IPR003054; Keratin_II.
PANTHER; PTHR23239; PTHR23239; 1.
Pfam; PF00038; Filament; 1.
Pfam; PF16208; Keratin_2_head; 2.
PRINTS; PR01276; TYPE2KERATIN.
SMART; SM01391; Filament; 1.
PROSITE; PS00226; IF_ROD_1; 1.
PROSITE; PS51842; IF_ROD_2; 1.
1: Evidence at protein level;
Coiled coil; Complete proteome; Disease mutation;
Intermediate filament; Keratin; Polymorphism; Reference proteome.
CHAIN 1 551 Keratin, type II cytoskeletal 75.
/FTId=PRO_0000314887.
DOMAIN 149 462 IF rod. {ECO:0000255|PROSITE-
ProRule:PRU01188}.
REGION 1 148 Head.
REGION 149 184 Coil 1A.
REGION 185 203 Linker 1.
REGION 204 296 Coil 1B.
REGION 297 319 Linker 12.
REGION 320 458 Coil 2.
REGION 459 551 Tail.
COMPBIAS 39 120 Gly-rich.
SITE 400 400 Stutter.
VARIANT 39 39 R -> C (in dbSNP:rs2232384).
/FTId=VAR_038098.
VARIANT 91 91 R -> G (in dbSNP:rs298109).
{ECO:0000269|PubMed:10692104,
ECO:0000269|PubMed:9856802}.
/FTId=VAR_038099.
VARIANT 117 117 P -> A (in dbSNP:rs2232386).
/FTId=VAR_038100.
VARIANT 161 161 A -> T (common polymorphism; may increase
risk to develop PFB; the variant is
disruptive at late stages of filament
assembly compromising the aggregation of
keratin molecules into intermediate
filaments; dbSNP:rs2232387).
{ECO:0000269|PubMed:15086549}.
/FTId=VAR_038101.
VARIANT 209 209 R -> Q (in dbSNP:rs2232390).
/FTId=VAR_038102.
VARIANT 242 242 E -> G (in dbSNP:rs2232393).
/FTId=VAR_038103.
VARIANT 337 337 E -> K (in LAHS; dbSNP:rs2232398).
{ECO:0000269|PubMed:11939812}.
/FTId=VAR_038104.
VARIANT 367 367 I -> V (in dbSNP:rs2232402).
/FTId=VAR_038105.
VARIANT 427 427 M -> T (in dbSNP:rs2232405).
/FTId=VAR_038106.
VARIANT 432 432 R -> C (in dbSNP:rs2232406).
/FTId=VAR_038107.
VARIANT 485 485 S -> R (in dbSNP:rs298104).
{ECO:0000269|PubMed:10692104,
ECO:0000269|PubMed:9856802}.
/FTId=VAR_038108.
CONFLICT 284 284 I -> S (in Ref. 1; CAA76730).
{ECO:0000305}.
SEQUENCE 551 AA; 59560 MW; 9099CD53A0BAF1EB CRC64;
MSRQSSITFQ SGSRRGFSTT SAITPAAGRS RFSSVSVARS AAGSGGLGRI SSAGASFGSR
SLYNLGGAKR VSINGCGSSC RSGFGGRASN RFGVNSGFGY GGGVGGGFSG PSFPVCPPGG
IQEVTVNQSL LTPLHLQIDP TIQRVRAEER EQIKTLNNKF ASFIDKVRFL EQQNKVLETK
WALLQEQGSR TVRQNLEPLF DSYTSELRRQ LESITTERGR LEAELRNMQD VVEDFKVRYE
DEINKRTAAE NEFVALKKDV DAAYMNKVEL EAKVKSLPEE INFIHSVFDA ELSQLQTQVG
DTSVVLSMDN NRNLDLDSII AEVKAQYEDI ANRSRAEAES WYQTKYEELQ VTAGRHGDDL
RNTKQEISEM NRMIQRLRAE IDSVKKQCSS LQTAIADAEQ RGELALKDAR AKLVDLEEAL
QKAKQDMARL LREYQELMNI KLALDVEIAT YRKLLEGEEC RLSGEGVSPV NISVVTSTLS
SGYGSGSSIG GGNLGLGGGS GYSFTTSGGH SLGAGLGGSG FSATSNRGLG GSGSSVKFVS
TTSSSQKSYT H


Related products :

Catalog number Product name Quantity
E1427h ELISA kit CK-2e,Cytokeratin-2e,Epithelial keratin-2e,Homo sapiens,Human,K2e,Keratin, type II cytoskeletal 2 epidermal,Keratin-2 epidermis,Keratin-2e,KRT2,KRT2A,KRT2E,Type-II keratin Kb2 96T
U1427h CLIA CK-2e,Cytokeratin-2e,Epithelial keratin-2e,Homo sapiens,Human,K2e,Keratin, type II cytoskeletal 2 epidermal,Keratin-2 epidermis,Keratin-2e,KRT2,KRT2A,KRT2E,Type-II keratin Kb2 96T
E1427h ELISA CK-2e,Cytokeratin-2e,Epithelial keratin-2e,Homo sapiens,Human,K2e,Keratin, type II cytoskeletal 2 epidermal,Keratin-2 epidermis,Keratin-2e,KRT2,KRT2A,KRT2E,Type-II keratin Kb2 96T
U1427r CLIA CK-2e,Cytokeratin-2e,Epithelial keratin-2e,K2e,Kb2,Keratin, type II cytoskeletal 2 epidermal,Keratin-2 epidermis,Keratin-2e,Krt2,Krt2a,Rat,Rattus norvegicus,Type-II keratin Kb2 96T
E1427r ELISA kit CK-2e,Cytokeratin-2e,Epithelial keratin-2e,K2e,Kb2,Keratin, type II cytoskeletal 2 epidermal,Keratin-2 epidermis,Keratin-2e,Krt2,Krt2a,Rat,Rattus norvegicus,Type-II keratin Kb2 96T
E1427r ELISA CK-2e,Cytokeratin-2e,Epithelial keratin-2e,K2e,Kb2,Keratin, type II cytoskeletal 2 epidermal,Keratin-2 epidermis,Keratin-2e,Krt2,Krt2a,Rat,Rattus norvegicus,Type-II keratin Kb2 96T
U2282h CLIA kit 67 kDa cytokeratin,CK-1,Cytokeratin-1,Hair alpha protein,Homo sapiens,Human,K1,Keratin, type II cytoskeletal 1,Keratin-1,KRT1,KRTA,Type-II keratin Kb1 96T
E2282h ELISA 67 kDa cytokeratin,CK-1,Cytokeratin-1,Hair alpha protein,Homo sapiens,Human,K1,Keratin, type II cytoskeletal 1,Keratin-1,KRT1,KRTA,Type-II keratin Kb1 96T
U2282h CLIA 67 kDa cytokeratin,CK-1,Cytokeratin-1,Hair alpha protein,Homo sapiens,Human,K1,Keratin, type II cytoskeletal 1,Keratin-1,KRT1,KRTA,Type-II keratin Kb1 96T
E2282h ELISA kit 67 kDa cytokeratin,CK-1,Cytokeratin-1,Hair alpha protein,Homo sapiens,Human,K1,Keratin, type II cytoskeletal 1,Keratin-1,KRT1,KRTA,Type-II keratin Kb1 96T
E2282h 67 kDa cytokeratin,CK-1,Cytokeratin-1,Hair alpha protein,Homo sapiens,Human,K1,Keratin, type II cytoskeletal 1,Keratin-1,KRT1,KRTA,Type-II keratin Kb1
E1427m ELISA CK-2e,Cytokeratin-2e,Epithelial keratin-2e,K2e,K2e,Keratin, type II cytoskeletal 2 epidermal,Keratin-2 epidermis,Keratin-2e,Krt2,Krt2-17,Krt2a,Mouse,Mus musculus,Type-II keratin Kb2 96T
U1427m CLIA CK-2e,Cytokeratin-2e,Epithelial keratin-2e,K2e,K2e,Keratin, type II cytoskeletal 2 epidermal,Keratin-2 epidermis,Keratin-2e,Krt2,Krt2-17,Krt2a,Mouse,Mus musculus,Type-II keratin Kb2 96T
E1427m ELISA kit CK-2e,Cytokeratin-2e,Epithelial keratin-2e,K2e,K2e,Keratin, type II cytoskeletal 2 epidermal,Keratin-2 epidermis,Keratin-2e,Krt2,Krt2-17,Krt2a,Mouse,Mus musculus,Type-II keratin Kb2 96T
U1427c CLIA Canis familiaris,Canis lupus familiaris,CK-2e,Cytokeratin-2e,Dog,Epithelial keratin-2e,K2e,K2E,Keratin, type II cytoskeletal 2 epidermal,Keratin-2 epidermis,Keratin-2e,KRT2,KRT2A,Type-II keratin 96T
E1427c ELISA Canis familiaris,Canis lupus familiaris,CK-2e,Cytokeratin-2e,Dog,Epithelial keratin-2e,K2e,K2E,Keratin, type II cytoskeletal 2 epidermal,Keratin-2 epidermis,Keratin-2e,KRT2,KRT2A,Type-II keratin 96T
U2287h CLIA kit CK-8,CYK8,Cytokeratin-8,Homo sapiens,Human,K8,Keratin, type II cytoskeletal 8,Keratin-8,KRT8,Type-II keratin Kb8 96T
E2287h ELISA CK-8,CYK8,Cytokeratin-8,Homo sapiens,Human,K8,Keratin, type II cytoskeletal 8,Keratin-8,KRT8,Type-II keratin Kb8 96T
E2287h ELISA kit CK-8,CYK8,Cytokeratin-8,Homo sapiens,Human,K8,Keratin, type II cytoskeletal 8,Keratin-8,KRT8,Type-II keratin Kb8 96T
U2287h CLIA CK-8,CYK8,Cytokeratin-8,Homo sapiens,Human,K8,Keratin, type II cytoskeletal 8,Keratin-8,KRT8,Type-II keratin Kb8 96T
E2287h CK-8,CYK8,Cytokeratin-8,Homo sapiens,Human,K8,Keratin, type II cytoskeletal 8,Keratin-8,KRT8,Type-II keratin Kb8
E1427c ELISA kit Canis familiaris,Canis lupus familiaris,CK-2e,Cytokeratin-2e,Dog,Epithelial keratin-2e,K2e,K2E,Keratin, type II cytoskeletal 2 epidermal,Keratin-2 epidermis,Keratin-2e,KRT2,KRT2A,Type-II ke 96T
U2282r CLIA kit CK-1,Cytokeratin-1,K1,Kb1,Keratin, type II cytoskeletal 1,Keratin-1,Krt1,Rat,Rattus norvegicus,Type-II keratin Kb1 96T
E2282r ELISA kit CK-1,Cytokeratin-1,K1,Kb1,Keratin, type II cytoskeletal 1,Keratin-1,Krt1,Rat,Rattus norvegicus,Type-II keratin Kb1 96T
E2282r ELISA CK-1,Cytokeratin-1,K1,Kb1,Keratin, type II cytoskeletal 1,Keratin-1,Krt1,Rat,Rattus norvegicus,Type-II keratin Kb1 96T

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Pathways :
WP1017: Type II interferon signaling (IFNG)
WP1136: Type II interferon signaling (IFNG)
WP1253: Type II interferon signaling (IFNG)
WP1289: Type II interferon signaling (IFNG)
WP1350: Type II interferon signaling (IFNG)
WP1584: Type II diabetes mellitus
WP2113: Type III interferon signaling
WP2272: Pathogenic Escherichia coli infection
WP585: Interferon type I
WP619: Type II interferon signaling (IFNG)
WP786: Type II interferon signaling (IFNG)
WP900: Type II interferon signaling (IFNG)

Related Genes :
[Krt71 K6irs1 Kb34 Krt2-6g Krt6g] Keratin, type II cytoskeletal 71 (Cytokeratin-6G) (CK-6G) (Cytokeratin-71) (CK-71) (Keratin-6G) (K6G) (Keratin-71) (K71) (Type II inner root sheath-specific keratin-K6irs1) (mK6irs) (mK6irs1/Krt2-6g) (Type-II keratin Kb34)
[KRT74 K6IRS4 KB37 KRT5C KRT6IRS4] Keratin, type II cytoskeletal 74 (Cytokeratin-74) (CK-74) (Keratin-5c) (K5C) (Keratin-74) (K74) (Type II inner root sheath-specific keratin-K6irs4) (Type-II keratin Kb37)
[KRT71 K6IRS1 KB34 KRT6IRS1] Keratin, type II cytoskeletal 71 (Cytokeratin-71) (CK-71) (Keratin-71) (K71) (Type II inner root sheath-specific keratin-K6irs1) (Keratin 6 irs) (hK6irs) (hK6irs1) (Type-II keratin Kb34)
[KRT72 K6IRS2 KB35 KRT6 KRT6IRS2] Keratin, type II cytoskeletal 72 (Cytokeratin-72) (CK-72) (Keratin-72) (K72) (Type II inner root sheath-specific keratin-K6irs2) (Type-II keratin Kb35)
[KRT1 KRTA] Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1) (CK-1) (Hair alpha protein) (Keratin-1) (K1) (Type-II keratin Kb1)
[KRT6C KRT6E] Keratin, type II cytoskeletal 6C (Cytokeratin-6C) (CK-6C) (Cytokeratin-6E) (CK-6E) (Keratin K6h) (Keratin-6C) (K6C) (Type-II keratin Kb12)
[KRT73 K6IRS3 KB36 KRT6IRS3] Keratin, type II cytoskeletal 73 (Cytokeratin-73) (CK-73) (Keratin-73) (K73) (Type II inner root sheath-specific keratin-K6irs3) (Type-II keratin Kb36)
[KRT6A K6A KRT6D] Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)
[Krt6a Ker2 Krt2-6 Krt2-6a Krt6] Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Keratin-6-alpha) (mK6-alpha) (Keratin-6A) (K6A)
[KRT6B K6B KRTL1] Keratin, type II cytoskeletal 6B (Cytokeratin-6B) (CK-6B) (Keratin-6B) (K6B) (Type-II keratin Kb10)
[KRT5] Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)
[KRT79 K6L KB38 KRT6L] Keratin, type II cytoskeletal 79 (Cytokeratin-79) (CK-79) (Keratin-6-like) (Keratin-6L) (Keratin-79) (K79) (Type-II keratin Kb38)
[Krt18 Kerd Krt1-18] Keratin, type I cytoskeletal 18 (Cytokeratin endo B) (Keratin D) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)
[KRT17] Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)
[KRT3] Keratin, type II cytoskeletal 3 (65 kDa cytokeratin) (Cytokeratin-3) (CK-3) (Keratin-3) (K3) (Type-II keratin Kb3)
[Krt17 Krt1-17] Keratin, type I cytoskeletal 17 (Cytokeratin-17) (CK-17) (Keratin-17) (K17)
[KRT19] Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)
[Krt16 Krt1-16] Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)
[KRT80 KB20] Keratin, type II cytoskeletal 80 (Cytokeratin-80) (CK-80) (Keratin-80) (K80) (Type-II keratin Kb20)
[KRT14] Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)
[Krt4 Krt2-4] Keratin, type II cytoskeletal 4 (Cytokeratin-4) (CK-4) (Cytoskeletal 57 kDa keratin) (Keratin-4) (K4) (Type-II keratin Kb4)
[KRT18 CYK18 PIG46] Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)
[KRT16 KRT16A] Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)
[KRT10 KPP] Keratin, type I cytoskeletal 10 (Cytokeratin-10) (CK-10) (Keratin-10) (K10)
[Krt18 Krt1-18] Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18)
[KRT85 KRTHB5] Keratin, type II cuticular Hb5 (Hair keratin K2.12) (Keratin-85) (K85) (Type II hair keratin Hb5) (Type-II keratin Kb25)
[KRT9] Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) (K9)
[KRT12] Keratin, type I cytoskeletal 12 (Cytokeratin-12) (CK-12) (Keratin-12) (K12)
[Krt17 Ka17] Keratin, type I cytoskeletal 17 (Cytokeratin-17) (CK-17) (Keratin-17) (K17) (Type I keratin Ka17)
[KRT34 HHA4 HKA4 KRTHA4] Keratin, type I cuticular Ha4 (Hair keratin, type I Ha4) (Keratin-34) (K34)

Bibliography :
?>